Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Lake

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Cancer Chemotherapy and Pharmacology|June 15, 2000
New chemotherapeutics in malignant mesothelioma: effects on cell growth and IL-6 productionB R McLaren, B W Robinson, R A Lake
Immunology and Cell Biology|April 2, 1999
MHC multimerization, antigen expression and the induction of APC amnesia in the developing immune responseR A Lake, B W Robinson, J D Hayball
Immunology and Cell Biology|August 1, 1997
A function for CD2 on murine B cells?M C Keogh, J Elliot, T Norton, et al.
Immunology|February 1, 1985
A key role for fibronectin in the sequential binding of native dsDNA and monoclonal anti-DNA antibodies to components of the extracellular matrix: its possible significance in glomerulonephritisR A Lake, A Morgan, B Henderson, et al.
European Journal of Immunology|May 1, 1994
Degeneracy of T cell receptor recognition of an influenza virus hemagglutinin epitope restricted by HLA-DQ and -DR class II moleculesC M Jones, R A Lake, J R Lamb, et al.
The Journal of Biological Chemistry|March 31, 1995
The high mobility group transcription factor, SOX4, transactivates the human CD2 enhancerD Wotton, R A Lake, C J Farr, et al.
European Journal of Immunology|January 1, 1991
Identification and functional analysis of the transcriptional enhancer of the human T cell receptor beta geneH M Prosser, R A Lake, D Wotton, et al.
Cancer Research|March 10, 1999
T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumorsA L Marzo, R A Lake, B W Robinson, et al.
International Immunology|May 1, 1993
CD28 mRNA rapidly decays when activated T cells are functionally anergized with specific peptideR A Lake, R E O'Hehir, A Verhoef, et al.
Cancer Chemotherapy and Pharmacology|August 8, 2001
Expression and integrity of DNA topoisomerase II isoforms does not explain generic drug resistance in malignant mesotheliomaB R McLaren, D Whitaker, B W Robinson, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Cancer Chemotherapy and Pharmacology|June 15, 2000
New chemotherapeutics in malignant mesothelioma: effects on cell growth and IL-6 productionB R McLaren, B W Robinson, R A Lake
Immunology and Cell Biology|April 2, 1999
MHC multimerization, antigen expression and the induction of APC amnesia in the developing immune responseR A Lake, B W Robinson, J D Hayball
Immunology and Cell Biology|August 1, 1997
A function for CD2 on murine B cells?M C Keogh, J Elliot, T Norton, et al.
Immunology|February 1, 1985
A key role for fibronectin in the sequential binding of native dsDNA and monoclonal anti-DNA antibodies to components of the extracellular matrix: its possible significance in glomerulonephritisR A Lake, A Morgan, B Henderson, et al.
European Journal of Immunology|May 1, 1994
Degeneracy of T cell receptor recognition of an influenza virus hemagglutinin epitope restricted by HLA-DQ and -DR class II moleculesC M Jones, R A Lake, J R Lamb, et al.
The Journal of Biological Chemistry|March 31, 1995
The high mobility group transcription factor, SOX4, transactivates the human CD2 enhancerD Wotton, R A Lake, C J Farr, et al.
European Journal of Immunology|January 1, 1991
Identification and functional analysis of the transcriptional enhancer of the human T cell receptor beta geneH M Prosser, R A Lake, D Wotton, et al.
Cancer Research|March 10, 1999
T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumorsA L Marzo, R A Lake, B W Robinson, et al.
International Immunology|May 1, 1993
CD28 mRNA rapidly decays when activated T cells are functionally anergized with specific peptideR A Lake, R E O'Hehir, A Verhoef, et al.
Cancer Chemotherapy and Pharmacology|August 8, 2001
Expression and integrity of DNA topoisomerase II isoforms does not explain generic drug resistance in malignant mesotheliomaB R McLaren, D Whitaker, B W Robinson, et al.
Pageof 5